Multi Hanna Kreasindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Hanna Kreasindo Tbk. trades at Rp137 (market cap 510B, 7.95M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multi Hanna Kreasindo Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multi Hanna Kreasindo Tbk. is more actively traded (7.95M versus 96.7K). Which is the better fit depends on your goals.
| MHKI | OBAT | |
|---|---|---|
Market Cap | 510B | 167.37B |
Volume | 7.95M | 96.7K |
Lot | 79.48K | 967 |
Turnover | 1.1B | 23.82M |
Average Price | 138.19 | 246.34 |
Value | 1.1B | 23.82M |
Indicative Equilibrium Price | 137 | 248 |
Indicative Equilibrium Volume | 911 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.
Read more on MHKI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →